EnVAX-A71

EnVAX-A71
Product Description

EnVAX-A71 is an inactivated enterovirus A71 (EV-A71) vaccine developed for the prevention of EV71-associated hand, foot and mouth disease (HFMD) and herpangina in infants and young children. Manufactured using a bioreactor-based process, EnVAX-A71 demonstrated 99.21% vaccine efficacy in a multicenter Phase III clinical trial with a favorable safety profile. The vaccine showed 100% efficacy in preventing EV71-associated hospitalization and severe complications. Cross-neutralization has been demonstrated against EV71 sub-genogroups B4, B5, C2, C4 and C5. Long-term follow-up showed sustained immunity with SPR of 100% at 2 years in Vietnam and 94.7% at 7 years in Taiwan.

Indication: Prevention of EV71-mediated HFMD and herpangina Dosage: 1 µg / 0.5 mL per dose (≥1.5 U per dose) Regimen: 2 doses, intramuscular injection, 28 days apart Age: 2 months to <6 years old

Read more Show less

ENIMMUNE CORPORATION

  • Country/Region:
    Taiwan
  • On CPHI since:
    2026
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Distributor/Import Export
View company profile
Categories
more categories Show less
Specifications
  • Details
    Indication: Prevention of EV71-mediated HFMD and HA Dosage: 1µg/0.5 mL/dose (≥ 1.5U per dose) Regimen: 2 doses, i.m., 28 days apart Age: 2 months to < 6 years old Cross-neutralization: B4, B5, C2, C4, C5 sub-genogroups
More specifications Fewer specifications

ENIMMUNE CORPORATION

  • Country/Region:
    Taiwan
  • On CPHI since:
    2026
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Distributor/Import Export
View company profile

More Products from ENIMMUNE CORPORATION (2)

  • AdimFlu-S

    Product AdimFlu-S

    AdimFlu-S is an inactivated seasonal influenza vaccine developed by Adimmune Corporation for the prevention of influenza infection. The vaccine contains influenza virus strains recommended annually by the World Health Organization and is designed to provide protection against circulating influenza viruses....
  • TETANUS TOXOID ALUM PRECIPITATED “KUO KWANG“

    Product TETANUS TOXOID ALUM PRECIPITATED “KUO KWANG“

    Tetanus Toxoid Alum Precipitated “KUO KWANG” is a sterile injectable vaccine indicated for active immunization against Tetanus. The vaccine contains purified tetanus toxoid adsorbed onto aluminum salts (alum) to enhance immunogenicity and induce protective antibody responses against the toxin produced by C...